Untargeted Metabolomics of Human Embryonic Kidney (HEK) Cell Line

Area of Science:

• Biochemistry
• Cell Biology
• Metabolomics

Background:

• Human embryonic kidney (HEK) cells are widely used in research due to their ease of maintenance and rapid growth.
• The fatty acid synthesis (FAS) pathway's metabolomic alterations are not well-documented.
• Understanding metabolic changes in HEK cells can inform research in other specialized cell types.

Purpose of the Study:

• To investigate the metabolomic changes associated with inhibiting the fatty acid synthesis (FAS) pathway in human embryonic kidney (HEK) cells.
• To provide insights into the upregulation and downregulation of metabolites within the FAS pathway.
• To establish a metabolomic profile in a well-characterized cell line for broader applications.

Main Methods:

• Utilizing human embryonic kidney (HEK) cells as a model system.
• Employing liquid chromatography-mass spectrometry (LC-MS) for sensitive metabolite analysis.
• Inhibiting the fatty acid synthesis (FAS) pathway to observe metabolic shifts.

Main Results:

• Detailed quantification and qualification of metabolites affected by FAS inhibition.
• Identification of specific upregulated and downregulated metabolites.
• Establishment of a comprehensive metabolomic dataset for HEK cells.

Conclusions:

• Inhibiting the fatty acid synthesis (FAS) pathway in HEK cells leads to significant, measurable metabolomic changes.
• The findings contribute to a deeper understanding of metabolic regulation in cellular systems.
• This research provides a valuable framework for future metabolomic studies in specialized cell types.